INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2004

Starch intake is associated with a 25-50% reduction in colorectal neoplasia, but direct evidence that resistant starch prevents colorectal cancer is lacking.

This review evaluates epidemiological, human intervention, and animal studies regarding resistant starch (RS) and colorectal cancer (CRC). Nine epidemiological studies evaluated starch and CRC or adenomas, with most showing a significant protective effect with a magnitude of protection in the order of 25-50%, though tools for measuring RS consumption remain poorly developed. Human intervention studies show RS softens stools, increases bulk, decreases pH, increases short-chain fatty acids including butyrate, reduces protein fermentation products, and decreases bile salts in fecal water within about 4 weeks. Animal studies confirm modifications to the lumenal environment and show RS increases apoptotic deletion of genetically damaged cells, though direct evidence for cancer protection remains unavailable.

Shows an association, not proof of cause and effect.

Study type
Narrative review
Who was studied
Human and animal studies evaluating starch and resistant starch intake
What was measured
Colorectal cancer, adenomas, and biomarkers of colonic biology

THE PAPER

Resistant starch and colorectal neoplasia.

Young GP, Le Leu RK. J AOAC Int, 2004.

PubMed 15287679 ↗

CancerGut & microbiome

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.